Suministro de Risperidona (DOE), Ondansetron(DOE), Levetiracetam (DOE), Ganciclovir (DOE) y Epoprostenol (DOE)
Published deadline passed
The published deadline has passed. For multi-stage competitions a later tender deadline may still apply — check the notice or portal for the current phase.
- Deadline
- Jul 8,Expired
- Agreement
- Buying goodsover 1 year
Brief
OSAKIDETZA ha modificado un contrato con KERN PHARMA, S.L., JANSSEN CILAG, S.A., ACCORD HEALTHCARE, S.L.U., NEUROXPHARM SPAIN, S.L. y NORMON para el suministro de Risperidona (DOE), Ondansetron (DOE), Levetiracetam (DOE), Ganciclovir (DOE) y Epoprostenol (DOE) en España. El contrato tiene una duración de 1 año y un valor final de 436.781 €.
Farmasøytisk engroshandel
Result
- ACCORD HEALTHCARE, S.L.U.Winner
- JANSSEN CILAG, S.A.Winner
- KERN PHARMA, S.L.Winner
- NEUROXPHARM SPAIN, S.L.,Winner
- NORMONWinner
- 0Number of tenders received
- €436,781Contract value
Previous winners
Who are you up against?
The suppliers who have won similar contracts at OSAKIDETZA - Servicio Vasco de Salud - Hospital Universitario Cruces (Impulsora)
Will you bid?
The agent sets up the bid and writes the first draft. Free for 14 days.
From the notice
Suministro de Risperidona (DOE), Ondansetron(DOE), Levetiracetam (DOE), Ganciclovir (DOE) y Epoprostenol (DOE)
Contact
Servicio de Farmaciacontrata@osakidetza.eus- ResultType
- Araba/ÁlavaLocation
- 33600000Main codePharmaceutical products